×
News Home

Should Drug Manufacturers - Specialty & Generic Stock Catalent Inc (CTLT) Be in Your Portfolio Tuesday?

Tuesday, May 04, 2021 11:03 AM | InvestorsObserver Analysts
Should Drug Manufacturers - Specialty & Generic Stock Catalent Inc (CTLT) Be in Your Portfolio Tuesday?

Catalent Inc (CTLT) is near the top in its industry group according to InvestorsObserver. CTLT gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Catalent Inc gets a 92 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 141 out of 148 industries.

Overall Score - 54
CTLT has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on CTLT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 54 would rank higher than 54 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Catalent Inc Stock Today?

Catalent Inc (CTLT) stock is trading at $104.08 as of 11:00 AM on Tuesday, May 4, a loss of -$7.70, or -6.89% from the previous closing price of $111.78. The stock has traded between $103.50 and $108.45 so far today. Volume today is 948,103 compared to average volume of 903,840.

Click Here to get the full Stock Score Report on Catalent Inc (CTLT) Stock.

You May Also Like